Jan 19, 2022 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Andras Attila Heczey and his team from Baylor College of Medicine on a clinical proteomics project focusing on leveraging our Complete360 body fluid proteomics assays for clinical discoveries.
Baylor College of Medicine (BCM) is a private, independent health sciences center in Houston, Texas within the Texas Medical Center, the world’s largest medical center. Dr. Andras Heczey is a physician-scientist and full-time faculty in the Department of Pediatrics of Baylor College of Medicine, Section of Pediatric Hematology and Oncology. He is a member of the multidisciplinary solid tumor team and the Center for Cell and Gene Therapy (CAGT).
Dr. Andras Heczey’s research focuses on developing novel treatments for patients with solid tumors by redirecting the immune system to attack cancer cells. As the Director of the Liver Tumor Center, Dr. Heczey has developed a strategy to target hepatoblastoma and hepatocellular carcinoma with genetically engineered T lymphocytes. This approach is evaluated in adults and children with liver cancer in two Phase 1 clinical trials.
The collaboration beween Complete Omics Inc and Dr. Heczey is focusing on very demanding body fluid proteomics assays which our unique patented Complete360 is designed to tackle.
